α-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines

Journal of Cellular Physiology

Volumn 194, Issue 3, 2003, Pages 325-340

  Van De Mark, Karyn ^a   Chen, James S ^a   Steliou, Kosta ^b   Perrine, Susan P ^a   Faller, Douglas V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; FAS ANTIGEN; HISTONE; PROTEIN P27; THIOCTIC ACID;

ACETYLATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BUTYRATES; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JURKAT CELLS; MICE; MICE, INBRED BALB C; THIOCTIC ACID; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

MURINAE;

EID: 0037362060     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10205     Document Type: Article

References (78)

1. 1 integrin loss from the cell surface. Cell 63:425-435.
2. 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol 115:829-841.
3. Atweh GF, Sutton M, Nassif I, Boosalis V, Dover GJ, Wallenstein S, Wright E, Mcmahon L, Stamatoyannopoulos G, Faller DV, Perrine SP. 1999. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 93:1790-1797.
4. Biewenga GPh, Haenen GRMM, Bast A. 1997. An overview of lipoate chemistry. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic acid in health and disease. New York: Marcel Dekker, Inc., NY. p 1-32.
5. Boosalis MS, Bandyopadhyay R, Bresnick EH, Pace BS, VanDeMark K, Zhang BH, Faller DV, Perrine SP. 2001. Shortchain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. Blood 97:3259-3267.
6. Borriello A, DellaPietra V, Criscuolo M, Oliva A, Tonini GP, Iolascon A, Zappia V, DellaRagione F. 2000. p27(Kip1) accumulation is associated with retinoic-induced neuroblastoma differentiation: Evidence of a decreased proteasome-dependent degradation. Oncogene 19:51-60.
7. Bustamante J, Slater A, Orrenius S. 1995. Antioxidant inhibition of thymocyte apoptosis by dihydrolipoic acid. Free Radical Biol Med 19:339-347.
8. Butke TM, Sandstrom PA. 1994. Oxidative stress as a mediator of apoptosis. Immunol Today 15:7-10.
9. Chen CY, Faller DV. 1995. Direction of p21(ras)-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 11:1487-1498.
10. Chen CY, Faller DV. 1996. Phosphorylation of Bcl-2 protein and association with p21(Ras) in Ras-induced apoptosis. J Biol Chem 271:2376-2379.
11. Chen CY, Faller DV. 1999. Selective inhibition of protein kinase C isozymes by Fas ligation. J Biol Chem 274:15320-15328.
12. Chen CY, Liou J, Forman LW, Faller DV. 1998a. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras. Cell Death Differ 5:984-995.
13. Chen CY, Liou J, Forman LW, Faller DV. 1998b. Differential regulation of discrete apoptotic pathways by Ras. J Biol Chem 273:16700-16709.
14. Chen CY, Juo P, Liou J, Yu Q, Blenis J, Faller DV. 2001. Activation of FADD and Caspase 8 in Ras-mediated apoptosis. Cell Growth Differ 12:297-306.
15. Chiarle R, Budel LM, Skolnik J, Frizzera G, Chilosi M, Corato A, Pizzolo G, Magidson J, Montagnoli A, Pagano M, Maes B, DeWolfPeeters C, Inghirami G. 2000. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 95:619-626.
16. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochem 18:5294-5299.
17. Coats S, Flanagan WM, Nourse J, Roberts JM. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880.
18. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. 1995. Mice lacking p21 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
19. Dikalov S, Khramtsov VV. 1997. Reaction of lipoate and its derivatives with reactive oxygen species. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic acid in health and disease. New York: Marcel Dekker, Inc., NY. p 47-66.
20. DiPersio CM, Hodivala-Dilke KM, Jaenisch R, Kreidberg JA. 1997. α3β1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol 137:729-742.
21. Dowling J, Yu Q-C, Fuchs E. 1996. β4 integrin is required for hemidesmosome formation, cell adhesion, and cell survival. J Cell Biol 134:559-572.
22. Downward J. 1997. Role of phosphoinositide-3-OH kinase in Ras signaling. Adv Second Messenger Phosphoprotein Res 31:1-10.
23. Eichhorst ST, Muller M, LiWeber M, SchulzeBergkamen H, Angel P, Krammer PH. 2000. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol 20:7826-7837.
24. Eichhorst ST, Muerkoster S, Weigand MA, Krammer PH. 2001. The chemotherapeutic drug 5-fluorouracil induces apoptosis in mouse thymocytes in vivo via activation of the CD95(APO-1/Fas) system. Cancer Res 61:243-248.
25. Eischen CM, Leibson PJ. 1997. The Fas pathway in apoptosis. In: Kaufmann SH, editor. Apoptosis. San Diego: Academic Press, Inc., San Diego, CA. p 107-132.
26. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Janicke RUU, Porter AG, Belka C, Gregor M, Schulzeosthoff K, Wesselborg S. 2000. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 19:4563-4573.
27. Eymin B, Sordet O, Droin N, Munsch B, Haugg M, VandeCraen M, Vandenabeele P, Solary E. 1999. Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27(Kip1) mediates its anti-apoptotic activity. Oncogene 18:4839-4847.
28. Faller DV, Mentzer SJ, Perrine SP. 2001. Induction of the Epstein-Barr Virus Thymidine Kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for EBV-associated malignancies. Curr Opin Oncol 13:367.
29. Fan Y-Y, Zhang J, Barhoumi R, Burghardt RC, Turner ND, Lupton JR, Chapkin RS. 1999. Antagonism of CD95 signaling blocks butyrate induction of apoptosis in young adult mouse colonic cells. Am J Physiol 277:C310-C319.
30. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744.
31. Ferreira CG, Tolis C, Span SW, Peters GJ, van Lopik T, Kummer AJ, Pinedo HM, Giaccone G. 2000. Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. Clin Cancer Res 6:203-212.
32. Flyer DC, Burakoff SJ, Faller DV. 1983. Expression of transfected viral glycoprotein genes on the cell surface; recognition and killing by virus-specific cytotoxic T-lymphocytes. Nature 305:315-318.
33. Friesen C, Fulda S, Debatin KM. 1999. Cytotoxic drugs and the CD95 pathway. Leukemia 13:1854-1858.
34. Frisch SM, Ruoslahti E. 1997. Integrins and anoikis. Curr Opin Cell Biol 9:701-706.
35. Fuchs J, Packer L, Zimmer G. 1997. Lipoic acid in health and disease. New York: Marcel Dekker, Inc., New York.
36. Fujieda S, Inuzuka M, Tanaka N, Sunaga HFG-KIT, Sugimoto C, Tsuzuki H, Saito H. 1999. Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int J Cancer 84:315-320.
37. Handelman GJ, Han D, Tritschler H, Packer L. 1994. Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem Pharmacol 47:1725-1730.
38. Hara I, Miyake H, Hara S, Arakawa S, Kamidono S. 2000. Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int J Oncol 17:1213-1218.
39. Hermann R, Niebch G. 1997. Human pharmacokinetics of α-lipoic acid. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic acid in health and disease. New York: Marcel Dekker, Inc., NY. p 337-360.
40. Hockenberry DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
41. Hodivala KJ, Watt FM. 1994. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 124:589-600.
42. Hofmann MA, Schiekofer S, Isermann B, Kanitz M, Henkels M, Joswig M, Treusch A, Morcos M, Weiss T, Borcea V, Abdel Khalek AK, Amiral J, Tritschler H, Ritz E, Wahl P, Ziegler R, Bierhaus A, Nawroth PP. 1999. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia 42:222-232.
43. Juo P, Woo MSA, Kuo CJ, Signorelli P, Biemann HP, Hannun YA, Blenis J. 1999. FADD is required for multiple signaling events downstream of the receptor Fas. Cell Growth Differ 10: 797-804.
44. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH, Seth P. 1997. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 57:5441-5445.
45. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544-548.
46. Kaufmann SH, Earnshaw WC. 2000. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256:42-49.
47. Khwaja A, Rodriguezviciana P, Wennstrom S, Warne PH, Downward J. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16:2783-2793.
48. Kim SY, Chu KC, Lee HR, Lee KS, Carey TE. 1997. Establishment and characterization of nine new head and neck cancer cell lines. Acta Oto Laryngol 117:775-784.
49. Kis K, Meier T, Multhoff G. 1997. Lipoate modulation of lymphocyte cysteine uptake. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic acid in health and disease lipoic acid in health and disease. New York: Marcel Dekker, Inc., NY. p 113-129.
50. Krishna S, Brown N, Faller DV, Spanjaard RA. 2002. Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells. Laryngoscope 112:645-650.
51. Liu ZG, Hsu HL, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death. Cell 87:565-576.
52. Mentzer SJ, Fingeroth J, Reilly JJ, Perrine SP, Faller DV. 1998. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr Virus EBV-associated lymphoma. Blood Cells Molecules Dis 24:114-123.
53. Mentzer SJ, Perrine SP, Faller DV. 2001. Epstein-Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: Pharmacological re-activation of viral target genes with arginine butyrate. Transplant Infec Dis 3:185.
54. Muraki Y, Tateishi A, Seta C, Fukuda J, Haneji T, Oya R, Ikemura K, Kobayashi N. 2000. Fas antigen expression and outcome of oral squamous cell carcinoma [In Process Citation]. Int J Oral Maxillofac Surg 29:360-365.
55. Nagarkatti N. 2000. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy. Cancer Immunol Immunother 49:46-55.
56. Newell MK, Desbarats J. 1999. Fas ligand: Receptor or ligand? Apoptosis 4:311-315.
57. Packer L, Roy S, Sen CK. 1997. α-Lipoic acid: A metabolic antioxidant and potential redox modulator of transcription. In: Advances in Pharmacology. San Diego: Academic Press, Inc., San Diego, CA. p 79-101.
58. Pagano M, Tam SW, Theodoras AM, Del Sal G, Yew PR, Draetta GF, Rolfe M. 1995. p27 levels are cell cycle-regulated by the ubiquitin-proteasome pathway. Science 269:682-685.
59. Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF. 1993. A short-term trial of butyrate to stimulate fetal-globin gene expression in the β-globin disorders. N Engl J Med 328:81-86.
60. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
61. Ramp U, Dejosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Lorenz I, Muller M, Krammer P, Gabbert HE, Gerharz CD. 2000. Deficient activation of CD95 APO-1/Fas-mediated apoptosis: A potential factor of multidrug resistance in human renal cell carcinoma. Brit J Cancer 82:1851-1859.
62. Rangan SRS. 1972. A new human cell line FaDu from a hypopharyngeal carcinoma. Cancer 29:117-122.
63. Sato N, Iwata S, Nakamura K, Hori T, Mori K, Yodoi J. 1995. Thiol-mediated redox regulation of apoptosis - Possible roles of cellular thiols other than glutathione in T cell apoptosis. J Immunol 154: 3194-3203.
64. Sen CK, Roy S, Derick H, Packer L. 1997. Regulation of cellular thiols in human lymphocytes by α-lipoic acid: A flow cytometric analysis. Free Radical Biol Med 22:1241-1257.
65. Sen CK, Sashwati R, Packer L. 1999. Fas mediated apoptosis of human Jurkat T-cells: Intracellular events and potentiation by redox-active alpha-lipoic acid. Cell Death Differ 6:481-491.
66. Sugiyama M, Speight PM, Prime SS, Watt FM. 1993. Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinomas. Carcinogenesis 14:2171-2176.
67. Suzuki YJ, Aggarwal BB, Packer L. 1992. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun 189:1709-1715.
68. Suzuki YJ, Mizuno M, Tritschler H, Packer L. 1995. Redox regulation of NFκB DNA binding activity by dihydrolipoate. Biochem Mol Biol Int 36:241-246.
69. Takahashi T, Tangiguchi T, Konishi H, Kikkawa U, Ishikawa Y, Yokayama M. 1999. Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells. Am J Physiol 276:H1927-H1934.
70. Toyoshima H, Hunter T. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
71. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. 1999. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274:22699-22704.
72. Van Waes C. 1995. Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing. Head Neck 17: 140-147.
73. Vaziri C, Stice L, Faller DV. 1998. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ 9:465-474.
74. Wu M, Lee HY, Bellas RE, Schauer SL, Arsura M, Katz D, Fitzgerald MJ, Rothstein TL, Sherr DH, Sonenshein GE. 1996. Inhibition of NF-kappa B/Rel induces apoptosis of murine B cells. EMBO J 15: 4682-4690.
75. Wu M, Bellas RE, Shen J, Yang W, Sonenshein GE. 1999. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J Immunol 163:6530-6535.
76. Yoshida M, Kijima M, Akita M, Beppu T. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174-17179.
77. Zhang X, Wharton W, Donovan M, Coppola D, Croxton R, Cress WD, Pledger WJ. 2000. Density-dependent growth inhibition of fibroblasts ectopically expressing p27kip1. Mol Biol Cell 11:2117-2130.
78. Zimmer G. 1997. Overview of the role of lipoate in the enzyme complexes of energy metabolism and reducing equivalents. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic acid in health and disease. New York: Marcel Dekker, Inc., NY. p 67-86.